Neutralizing antibodies directed against SARS-CoV-2 in a population residing in a nursing home and a long-term care unit
Geriatr Gerontol Int
.
2021 Nov;21(11):1066-1068.
doi: 10.1111/ggi.14289.
Epub 2021 Oct 1.
Authors
Julien Moyet
1
,
Francois Helle
2
,
Gwladys Bourdenet
3
4
,
Cédric Joseph
5
,
Brigitte Gubler
3
4
6
,
Etienne Brochot
2
7
,
Frédéric Bloch
1
8
Affiliations
1
Department of Gerontology, Amiens University Hospital, Amiens, France.
2
AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France.
3
Department of Immunology, Amiens University Hospital, Amiens, France.
4
HEMATIM - EA4666, Jules Verne University of Picardie, Amiens, France.
5
Infectious Diseases Department, Amiens University Hospital, Amiens, France.
6
Department of Molecular Oncobiology, Amiens University Hospital, Amiens, France.
7
Department of Virology, Amiens University Hospital, Amiens, France.
8
Laboratory of Functional Neurosciences UR 4559, Jules Verne University of Picardie, Amiens, France.
PMID:
34595810
PMCID:
PMC8653212
DOI:
10.1111/ggi.14289
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Neutralizing
Antibodies, Viral
COVID-19*
Humans
Long-Term Care
Nursing Homes
SARS-CoV-2*
Substances
Antibodies, Neutralizing
Antibodies, Viral
Grants and funding
AGIPI